+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Dental Bone Grafts and Substitutes Market, By Product, By Treatment Type, By Application, By End User Estimation & Forecast, 2018-2031

  • PDF Icon

    Report

  • 328 Pages
  • July 2023
  • Region: Europe
  • Astute Analytica
  • ID: 5864769

The Europe dental bone grafts and substitutes market held a market value of USD 256.21 million in 2022 and is estimated to reach USD 468.75 million by the year 2031

The Europe dental bone grafts and substitutes market held a market value of USD 256.21 million in 2022 and is estimated to reach USD 468.75 million by the year 2031. The market is projected to list a CAGR of 7.09% during the forecast period.

The market for dental bone grafts and substitutes in Europe is driven by several factors, including the growing demand for dental implant surgeries, the increasing prevalence of dental disorders such as periodontal diseases, and the rising geriatric population. Additionally, the development of biocompatible synthetic bone grafts is a significant driver for the market.

Other drivers of the market include advancements in implant technology, the increasing popularity of cosmetic dentistry, and the rising demand for minimally invasive surgical procedures. As a result, the dental bone grafts and substitutes market in Europe is poised for continued growth in the coming years.

Growth Influencers:

Development of biocompatible synthetic bone grafts
Synthetic bone grafts are becoming increasingly popular due to their ability to mimic natural bone and their biocompatibility. They are made from materials such as calcium phosphate, hydroxyapatite, and tricalcium phosphate, which are similar in composition to the minerals found in natural bone. Synthetic bone grafts have several advantages over traditional bone grafts, including their ability to be molded and shaped to fit the surgical site, their consistent quality and availability, and their reduced risk of disease transmission.

The development of biocompatible synthetic bone grafts has led to a surge in demand for these products, driving growth in the dental bone grafts and substitutes market in Europe. The market is expected to continue growing in the coming years as more advanced synthetic bone grafts are developed and introduced into the market.

Increase in demand for dental bone grafts
The prevalence of dental disorders such as periodontal diseases, tooth decay, and oral cancer is increasing in Europe. This has led to a rise in demand for dental bone grafts and substitutes, as these materials are used to treat various dental disorders. Moreover, with an aging population in Europe, there is an increasing need for dental implants and other restorative procedures. Dental bone grafts and substitutes play a crucial role in these procedures, as they provide a base for the implant to attach to.

In addition to that, there is a growing awareness about the importance of dental health in Europe, which has led to an increase in the number of people seeking dental treatments. This, in turn, has driven the demand for dental bone grafts and substitutes.

Segments Overview:

The Europe dental bone grafts and substitutes market is segmented into Type, product, treatment type, application, and end user.

By Type

  • PCR-based Assays
  • ELISA-based Assays

By Product

  • Xenograft
  • Autograft
  • Allograft
  • Synthetic
The autograft segment held the highest market share with 55% in 2022. Moreover, segment is also anticipated to grow highest at a rate of 8.5% over the forecast period.

By Treatment Type

Natural bone grafts

  • Autologous bone grafts
  • Cancellous autografts
  • Cortical autografts
  • Allogeneic bone grafts
  • Cancellous allografts
  • Demineralized bone matrix (DBM)

Synthetic bone graft substitutes

  • Calcium sulphate
  • Calcium phosphate ceramics (CaP ceramics)
  • Tricalcium phosphate (TCP)
  • Biphasic calcium phosphate (BCP)
  • Calcium phosphate cements (CPC)
  • Others
  • Others
The natural bone grafts segment held the highest market share of 36% in 2022. Moreover, the synthetic bone grafts substitutes segment is estimated to be the fastest growing segment with a CAGR of 8.5%.

By Application

  • Research & Development
  • Clinical Applications
The clinical applications segment held the highest market share with 58% in 2022. The segment is also expected to grow highest with a rate of 8.7% over the forecast period.

By End User

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Academic & Research Institutes
The contract manufacturing organizations segment held the highest market share of more than 44% in 2022.

Regional Overview

Based on region, the Europe dental bone grafts and substitutes market has been segmented into the UK, Germany, France, Italy, Spain, Netherlands, Turkey, Rest of Europe. The France market for dental bone grafts and substitutes held the highest market share in 2022, along with being the fastest growing region.

Competitive Landscape

Dentsply Sirona, Biohorizons Inc., Zimmer Biomet, RTI Surgicals, Medtronic, Geistlich Pharma Ag, and others are some of the well-known companies active in the Europe dental bone grafts and substitutes market. Approximately 50% of the market is controlled by the top four players. For instance, in February 2022, Zimmer Biomet Holdings, Inc. introduced Overdentures, a cutting-edge overdenture fixation technique for Zimmer Biomet dental implants, in North America and Europe. This new product line comes with a zirconium nitride abutment coating for better looks and functionality, as well as a wider range of abutment sizes for greater restorative versatility. It all comes in a user-friendly, conventional system design.

The Europe dental bone grafts and substitutes market report provides insights on the below pointers:

  • Market Penetration: Provides comprehensive information on the market offered by the prominent players
  • Market Development: The report offers detailed information about lucrative emerging markets and analyzes penetration across mature segments of the markets
  • Market Diversification: Provides in-depth information about untapped geographies, recent developments, and investments
  • Competitive Landscape Assessment: Mergers & acquisitions, certifications, product launches in the Europe dental bone grafts and substitutes market have been provided in this research report. In addition, the report also emphasizes the SWOT analysis of the leading players.
  • Product Development & Innovation: The report provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
  • Pricing Analysis: Pricing analysis of various components used in the manufacturing
  • Manufacturing Cost Analysis: Cost-share of various components
  • Dental Support Organizations
  • Trends and Developments- Dental Bone Grafts and Substitutes Market
  • Funding Process for Bone Grafts and Substitutes

The Europe dental bone grafts and substitutes market report answers questions such as:

  • What is the market size and forecast of the Europe dental bone grafts and substitutes market?
  • What are the inhibiting factors and impact of COVID-19 on the Europe dental bone grafts and substitutes market during the assessment period?
  • Which are the products/segments/applications/areas to invest in over the assessment period in the Europe dental bone grafts and substitutes market?
  • What is the competitive strategic window for opportunities in the Europe dental bone grafts and substitutes market?
  • What are the technology trends and regulatory frameworks in the Europe dental bone grafts and substitutes market?
  • What is the market share of the leading players in the Europe dental bone grafts and substitutes market?
  • What modes and strategic moves are considered favorable for entering the Europe dental bone grafts and substitutes market?

Table of Contents

Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Europe Dental Bone Grafts and Substitutes Market
Chapter 4. Europe Dental Bone Grafts and Substitutes Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Material provider
4.1.2. Manufacturer
4.1.3. Service Provider
4.1.4. End User
4.2. Industry Outlook
4.2.1. Overview of Dental Bone Grafts and Substitutes Market
4.2.1.1. List of Major DSOs
4.2.1.2. Recent Mergers & Acquisitions
4.2.1.3. List of Major HMOs
4.2.2. Trends and Developments- Dental Bone Grafts and Substitutes Market
4.2.4. Funding Process for Bone Grafts and Substitutes
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.3. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2018 - 2031
4.7.1. Price Trend Analysis
4.7.1.1 Top Players, By Country, By Product, By SKU*
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2022
4.8.3. Competitor Mapping
Chapter 5. Europe Dental Bone Grafts and Substitutes Market Analysis, By Product
5.1. Key Insights
5.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
5.2.1. Xenograft
5.2.2. Autograft
5.2.3. Allograft
5.2.4. Synthetic analysis
Chapter 6. Europe Dental Bone Grafts and Substitutes Market Analysis, By Treatment Type
6.1. Key Insights
6.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
6.2.1. Natural bone grafts
6.2.1.1. Autologous bone grafts
6.2.1.1.1. Cancellous autografts
6.2.1.1.2. Cortical autografts
6.2.1.2. Allogeneic bone grafts
6.2.1.2.1. Cancellous allografts
6.2.1.2.2. Demineralized bone matrix (DBM)
6.2.2. Synthetic bone graft substitutes
6.2.2.1. Calcium sulphate
6.2.2.2. Calcium phosphate ceramics (CaP ceramics)
6.2.2.2.1. Tricalcium phosphate (TCP)
6.2.2.2.2. Biphasic calcium phosphate (BCP)
6.2.2.3. Calcium phosphate cements (CPC)
6.2.2.4. Others
6.2.3. Others
Chapter 7. Europe Dental Bone Grafts and Substitutes Market Analysis, By Application
7.1. Key Insights
7.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
7.2.1. Research & Development
7.2.2. Clinical Applications
Chapter 8. Europe Dental Bone Grafts and Substitutes Market Analysis, By End User
8.1. Key Insights
8.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
8.2.1. Biopharmaceutical Companies
8.2.2. Contract Research Organizations
8.2.3. Contract Manufacturing Organizations
8.2.4. Academic & Research Institutes
Chapter 9. Europe Dental Bone Grafts and Substitutes Market Analysis, By Country
9.1. Key Insights
9.2. Market Size and Forecast, 2018 - 2031 (US$ Mn)
9.2.1. The UK
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Netherlands
9.2.7. Turkey
9.2.8. Rest of Europe
Chapter 10. The UK Dental Bone Grafts and Substitutes Market Analysis
10.1. Country Profile
10.1.2. Major DSOs
10.1.2. HMOs
10.1.3. Market Dynamics
10.1.4. Key Players Market share Analysis
10.2. Key Insights
10.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
10.2.1. By Treatment Type
10.2.2. By Application
10.2.3. By End User
Chapter 11. Germany Dental Bone Grafts and Substitutes Market Analysis
11.1. Country Profile
11.1.1. Major DSOs
11.1.2. HMOs
11.1.3. Market Dynamics
11.1.4. Key Players Market share Analysis
11.2. Key Insights
11.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
11.3.1. By Treatment Type
11.3.2. By Application
11.3.3. By End User
Chapter 12. France Dental Bone Grafts and Substitutes Market Analysis
12.1. Country Profile
12.1.1. Major DSOs
12.1.2. HMOs
12.1.3. Market dynamics
12.1.4. Key players Market share Analysis
12.2. Key Insights
12.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
12.3.1. By Treatment Type
12.3.2. By Application
12.3.3. By End User
Chapter 13. Italy Dental Bone Grafts and Substitutes Market Analysis
13.1. Country Profile
13.1.1. Major DSOs
13.1.2. HMOs
13.1.3. Market dynamics
13.1.4. Key players Market share Analysis
13.2. Key Insights
13.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
13.3.1. By Treatment Type
13.3.2. By Application
13.3.3. By End User
Chapter 14. Spain Dental Bone Grafts and Substitutes Market Analysis
14.1. Country Profile
14.1.1. Major DSOs
14.1.2. HMOs
14.1.3. Market dynamics
14.1.4. Key players Market share Analysis
14.2. Key Insights
14.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
14.3.1. By Treatment Type
14.3.2. By Application
14.3.3. By End User
Chapter 15. Netherlands Dental Bone Grafts and Substitutes Market Analysis
15.1. Country Profile
15.1.1. Major DSOs
15.1.2. HMOs
15.1.3. Market dynamics
15.1.4. Key players Market share Analysis
15.2. Key Insights
15.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
15.3.1. By Treatment Type
15.3.2. By Application
15.3.3. By End User
Chapter 16. Turkey Dental Bone Grafts and Substitutes Market Analysis
16.1. Country Profile
16.1.1. Major DSOs
16.1.2. HMOs
16.1.3. Market dynamics
16.1.4. Key players Market share Analysis
16.2. Key Insights
16.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
16.3.1. By Treatment Type
16.3.2. By Application
16.3.3. By End User
Chapter 17. India Dental Bone Grafts and Substitutes Market Analysis
17.1. Country Profile
17.1.1. Major DSOs
17.1.2. HMOs
17.1.3. Market dynamics
17.1.4. Key players Market share Analysis
17.2. Key Insights
17.3. Market Size and Forecast, 2018 - 2031 (US$ Mn)
17.3.2. By Treatment Type
17.3.3. By Application
17.3.4. By End User
Chapter 18. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
18.1. Ivoclar Vivadent
18.2. Zimmer Biomet
18.3. DENTSPLY SIRONA
18.4. Nobel Biocare
18.7. Medtronic
18.8. BioHorizons IPH, Inc.
18.9. ACE Surgical Supply Company
18.10. Geisclich Pharma AG
18.11. Straumann Group

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ivoclar Vivadent
  • Zimmer Biomet
  • DENTSPLY SIRONA
  • Nobel Biocare
  • Medtronic
  • BioHorizons IPH, Inc.
  • ACE Surgical Supply Company
  • Geisclich Pharma AG
  • Straumann Group

Table Information